Advancing Cell Therapy With The CTS DynaCellect Magnetic Separation System

Achieving consistent, high-purity T cell isolation is one of the most critical and unforgiving steps in cell therapy manufacturing. Variability at this stage can compromise downstream processes, increase costs, and ultimately delay therapies reaching patients. The Gibco CTS DynaCellect Magnetic Separation System was built to address these challenges head-on, combining automated closed-system processing with programmable flexibility to deliver isolation efficiency above 85% and purity exceeding 96%.

This brochure details the system's integrated magnet rocker and fluidics panel, its compatibility with CTS Detachable Dynabeads, and how processing times can be reduced to as little as 70 minutes. Internal study data on viability, purity, and reproducibility across multiple donors is included alongside full specifications and ordering details. For teams navigating the path from process development to CGMP clinical manufacturing, this resource makes the case for a platform designed to scale with you.